Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Int J Endocr Oncol. 2015;2(2):159–168. doi: 10.2217/ije.14.40

Figure 1. Triple phase CT scan demonstrating approximately 70% replacement of the liver by enhancing neuroendocrine tumor metastases.

Figure 1

(A) Arterial phase, (B) venous phase and (C) equilibrium phase of delayed images. Note that hyperenhancing lesions are most clearly seen on arterial phase.